How can we improve oral contraceptive success in obese women?

Ganesh Cherala, Alison Edelman

Research output: Contribution to journalArticle

Abstract

A rapid increase in obesity rates worldwide further underscores the importance of better understanding the pharmacokinetic alterations in this sub-population and the subsequent effects on pharmacotherapeutics. Pharmacokinetics of contraceptive steroids is altered in obese oral contraceptive users, which may in turn impact efficacy. Our study has identified several dosing strategies that offset these pharmacokinetic changes and may improve effectiveness for obese oral contraception users.

Original languageEnglish (US)
Pages (from-to)1-3
Number of pages3
JournalExpert Review of Clinical Pharmacology
Volume8
Issue number1
DOIs
StatePublished - Jan 1 2014

Fingerprint

Oral Contraceptives
Pharmacokinetics
Contraceptive Agents
Contraception
Obesity
Steroids
Population

Keywords

  • drug failure
  • obesity
  • oral contraception
  • pharmacokinetics
  • steroidal hormones

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Medicine(all)

Cite this

How can we improve oral contraceptive success in obese women? / Cherala, Ganesh; Edelman, Alison.

In: Expert Review of Clinical Pharmacology, Vol. 8, No. 1, 01.01.2014, p. 1-3.

Research output: Contribution to journalArticle

@article{b853f41e3c834972a62ba9c85dcd1e04,
title = "How can we improve oral contraceptive success in obese women?",
abstract = "A rapid increase in obesity rates worldwide further underscores the importance of better understanding the pharmacokinetic alterations in this sub-population and the subsequent effects on pharmacotherapeutics. Pharmacokinetics of contraceptive steroids is altered in obese oral contraceptive users, which may in turn impact efficacy. Our study has identified several dosing strategies that offset these pharmacokinetic changes and may improve effectiveness for obese oral contraception users.",
keywords = "drug failure, obesity, oral contraception, pharmacokinetics, steroidal hormones",
author = "Ganesh Cherala and Alison Edelman",
year = "2014",
month = "1",
day = "1",
doi = "10.1586/17512433.2015.974558",
language = "English (US)",
volume = "8",
pages = "1--3",
journal = "Expert Review of Clinical Pharmacology",
issn = "1751-2433",
publisher = "Expert Reviews Ltd.",
number = "1",

}

TY - JOUR

T1 - How can we improve oral contraceptive success in obese women?

AU - Cherala, Ganesh

AU - Edelman, Alison

PY - 2014/1/1

Y1 - 2014/1/1

N2 - A rapid increase in obesity rates worldwide further underscores the importance of better understanding the pharmacokinetic alterations in this sub-population and the subsequent effects on pharmacotherapeutics. Pharmacokinetics of contraceptive steroids is altered in obese oral contraceptive users, which may in turn impact efficacy. Our study has identified several dosing strategies that offset these pharmacokinetic changes and may improve effectiveness for obese oral contraception users.

AB - A rapid increase in obesity rates worldwide further underscores the importance of better understanding the pharmacokinetic alterations in this sub-population and the subsequent effects on pharmacotherapeutics. Pharmacokinetics of contraceptive steroids is altered in obese oral contraceptive users, which may in turn impact efficacy. Our study has identified several dosing strategies that offset these pharmacokinetic changes and may improve effectiveness for obese oral contraception users.

KW - drug failure

KW - obesity

KW - oral contraception

KW - pharmacokinetics

KW - steroidal hormones

UR - http://www.scopus.com/inward/record.url?scp=84916879356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84916879356&partnerID=8YFLogxK

U2 - 10.1586/17512433.2015.974558

DO - 10.1586/17512433.2015.974558

M3 - Article

C2 - 25354219

AN - SCOPUS:84916879356

VL - 8

SP - 1

EP - 3

JO - Expert Review of Clinical Pharmacology

JF - Expert Review of Clinical Pharmacology

SN - 1751-2433

IS - 1

ER -